Health Condition 1: H- Substance Abuse Treatment
Conditions
Interventions
Intervention1: Developed multi component intervention on the principles of CBT, MET and Brief intervention + 5A intervention: Duration of Intervention:20-30 minutes
Components of intervention:
1. Biomarker (Salivary cotinine levels) feedback Salivary cotinine, a metabolite of nicotine, is a biomarker of overall tobacco use. This study
will use salivary cotinine l
Sponsors
ICMR
Eligibility
Inclusion criteria
Inclusion criteria: Inclusion criteria for pregnant females Women with 12 weeks or less than 12 weeks pregnancy Smokeless tobacco uses within last 2 days Visiting in the antenatal clinic Aged 18 or above Communicate in Hindi or English Inclusion criteria for non pregnant females Smokeless tobacco uses within last 2 days Aged 18 or above Communicate in Hindi or English Age, education, and socio-economic status matched with pregnant females
Exclusion criteria
Exclusion criteria: Exclusion criteria for pregnant females Those with unstable medical conditions as advised by the doctor in charge Poor cognitive state Having mental illness Those participating in other tobacco cessation program Exclusion criteria for non pregnant females Those with unstable medical conditions as advised by the doctor in charge Poor cognitive state Having mental illness Those participating in other tobacco cessation program
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Estimate recruitment and retention rates. 30 days Point prevalence abstinence in late pregnancy (32 weeks) (self-reported tobacco use status will be obtained and will be biochemically verified through use urine cotinine testing) Timepoint: 32 weeks Pregnancy | — |
Secondary
| Measure | Time frame |
|---|---|
| Continued abstinence in late pregnancy (32 weeks) after quitting in early pregnancy (self-reported tobacco use status will be obtained & will be biochemically verified through use of urine cotinine testing). Smokeless tobacco reduction from the first antenatal visit to late pregnancy (32weeks): Any reducing quantity of smokeless tobacco (self-Reported) Timepoint: Baseline, 4 weeks & 32 weeks | — |
Countries
India
Contacts
Public ContactDr Parbhoo Dayal
All India Institute of Medical Sciences, New Delhi
Outcome results
None listed